Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Acq. completed
CC transcript
Director departure
|
|
BIO-RAD LABORATORIES, INC. (BIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/13/2011 |
MW
| Bio-Rad to Report First-Quarter 2011 Financial Results Tuesday, May 3, 2011 |
| 02/24/2011 |
MW
| Bio-Rad Reports Record Fourth-Quarter and Full-Year 2010 Financial Results |
| 01/26/2011 |
MW
| Bio-Rad to Report Fourth-Quarter and Full-Year 2010 Financial Results Thursday, February 24, 2011 |
| 12/06/2010 |
MW
| Bio-Rad Announces Pricing of Public Offering of $425 Million Senior Notes |
| 12/06/2010 |
MW
| Bio-Rad Announces Public Offering of $425 Million Senior Notes |
| 11/02/2010 |
MW
| Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of More Than 5 Percent |
| 10/13/2010 |
MW
| Bio-Rad and Axis-Shield Announce FDA Clearance and U.S. Launch of an Anti-CCP Test for Rheumatoid Arthritis for Bio-Rad's BioPlex 2200 System |
| 10/12/2010 |
MW
| Bio-Rad to Report Third-Quarter 2010 Financial Results Tuesday, November 2, 2010 |
| 08/03/2010 |
MW
| Bio-Rad Reports Second-Quarter Currency-Neutral Revenue Growth of 9 Percent |
| 07/26/2010 |
MW
| Bio-Rad Submits Premarket Approval Application to the FDA for Its Fourth-Generation HIV Assay |
| 07/12/2010 |
MW
| Bio-Rad to Report Second-Quarter 2010 Financial Results Tuesday, August 3, 2010 |
| 06/30/2010 |
MW
| Bio-Rad Introduces its IH 1000, an Automated Blood Screening System |
| 05/10/2010 |
MW
| Bio-Rad Receives Notification From the FDA That It May Proceed With an Investigational New Drug Study for Its Dengue NS1 Ag Microplate Assay |
| 05/10/2010 |
MW
| Bio-Rad Named One of the 'Best Places to Work' in the San Francisco Bay Area for 2010 |
| 04/12/2010 |
MW
| Bio-Rad to Report First-Quarter 2010 Financial Results Tuesday, May 4, 2010 |
| 03/25/2010 |
MW
| Bio-Rad Announces the Appointment of New Board Member |
|
|